Eovist

Active Ingredient(s): Gadoxetate Disodium
FDA Approved: * July 3, 2008
Pharm Company: * BAYER HLTHCARE
Category: Diagnostic Aid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Eovist Overview

Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1] See also Gadobenic acid Gadopentetic acid References ^ "Eovist - Homepage". Retrieved 2009-03-22..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:i...

Read more Eovist Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadoxetic_acid

Recent Eovist Forums: RSS Feed

EOvist in renally impaired patients

Since 50% of the excretion is by the liver - I would think this is the ideal contrast for any patient with renal compromise. I know there is currently a clinical trial for this. however as in all cases the science and the prelimiary data seems so promising that I think this needs to be considered for the renal impaired patients. There are many patients who need contrast who have renal failure. The fact that this cojntrast is already 1/4 dose regular contrast and you could use this 1/2 dose at 3T for renal impaired patients would for me be perfectly acceptable if this finds the small liver met or small brain met which could not be detected otherwise. Benefits vs risks are what we balance every day. I am happy to hear your comments on this.

Updated

Possible Dosages for this and Related Drugs:

Gadoxetate Disodium
  • Injection: o.1ml
  • Solution: 1.8143gm/10ml (181.43mg/ml), 1.8143gm/10ml(181.43mg/ml), 2.72145gm/15ml (181.43mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eovist: (1 result)

Sorted by National Drug Code
  • 50419-320 Eovist 181.43 mg/ml Intravenous Injection, Solution by Bayer Healthcare Pharmaceuticals Inc.

Other drugs which contain Gadoxetate Disodium or a similar ingredient: (1 result)

Related Eovist Topics:

EOvist in renally impaired patients
Since 50% of the excretion is by the liver - I would think this is the ideal contrast for any patient with renal comprom...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA